Otolaryngology

Clinical evidence, research, and medical intelligence in Otolaryngology.

Tonsillectomy Pain Trial Compares Ropivacaine and Lidocaine

BMJ Open protocol for a double-blinded trial testing whether ropivacaine or lidocaine better reduces postoperative pain after tonsillectomy.

By Dr. A. Nikhil Krishnan, MBBS · 3 days ago · 5 min read

Otolaryngology·JAMA

Academic Rhinologist Job Listing at UAMS

JAMA Career Center listing for an academic rhinologist position in Little Rock, Arkansas, at the University of Arkansas…

3 days ago

Otolaryngology·KFF

FDA Approves First DNA-Based Immunotherapy for Recurrent Respiratory Papillomatosis

The FDA granted accelerated approval to Voceryq for recurrent respiratory papillomatosis, aiming to reduce repeated airway surgeries in…

7 days ago

Otolaryngology·JAMA

Otolaryngology faculty diversity study finds racial and gender gaps

A cross-sectional study of 102 otolaryngology programs found persistent underrepresentation, fewer citations for URiM faculty, and broader productivity…

Nov 6, 2026

Otolaryngology·MedCity

FDA Approves Inovio DNA Immunotherapy for RRP in Adults

Inovio won FDA approval for Voceryq in adult recurrent respiratory papillomatosis, offering a new option to reduce repeated…

Nov 3, 2026

Otolaryngology·Becker H

Cisplatin Hearing Loss Can Progress Long After Chemotherapy Ends

A review explains why cisplatin ototoxicity can worsen after treatment, with platinum retention in the cochlea and implications…

Nov 2, 2026

Otolaryngology·FDA

FDA Approves Voceryq for Recurrent Respiratory Papillomatosis

FDA grants accelerated approval to Voceryq, the first plasmid DNA-based immunotherapy for adults with recurrent respiratory papillomatosis.

Oct 31, 2026

Otolaryngology·JAMA

Oxymetazoline-Budesonide Trial Eases Chronic Nasal Obstruction

A randomized trial found oxymetazoline-budesonide improved chronic nasal obstruction more than budesonide alone, without rebound during short-term use.

Oct 30, 2026

Otolaryngology·Nature

Therapeutic electrical stimulation speeds recurrent laryngeal nerve repair in rats

In a rat recurrent laryngeal nerve crush model, therapeutic electrical stimulation improved vocal fold motion, nerve conduction, and…

Oct 28, 2026

Otolaryngology·DailyMed

Menthol Cough Drops Label Adds Safety Limits for Sore Throat Use

DailyMed label details menthol cough drops for temporary cough and sore throat relief, with clear stop-use warnings and…

Oct 26, 2026

Otolaryngology

Clinical evidence, research, and medical intelligence in Otolaryngology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.